Patent · US Active

Bis(thio-hydrazide amide) salts for treatment of cancers

US7795313B2 · kind B2 · utility

13Cited by

37References

18Claims

0Family size

Assignee

Synta Pharmaceuticals Corp. · US

Inventors

Keizo Koya · Sharon, US
Lijun Sun · Harvard, US
Elena Kostik · Arlington, US
Farid Vaghefi · Santa Clarita, US
Shoujun Chen · Bedford, US
Noriaki Tatsuta · Lexington, US
Guiqing Liang · Concord, US
Takayo Inoue · Tokyo, JP
Zhi-Qiang Xia · Acton, US

Key dates

Filing date	Jul 15, 2009
Grant date	Sep 14, 2010
Priority date	—
Expiry date	Jul 15, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I): Also, disclosed are pharmaceutical compositions comprising a bis(thio-hydrazide amide) disalt described above. Further disclosed are methods of treating a subject with cancer. The methods comprise the step of administering an effective amount of a bis(thio-hydrazide amide) disalt described above.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.